References
- 1. CIUREA T., CAZACU S.M., GHEONEA D.I., ROGOVEANU I., SĂFTOIU A., VERE C.C. Pancreatitele cronice. În: MedicinaInterna – Gastroenterologie, Craiova: Ed. MedicalăUniversitară, 2015: 289-97.
- 2. YADAV D., LOWENFELS A.B. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013; 144(6):1252-61.
- 3. YANG A.L., VADHAVKAR S., SINGH G., OMARY M.B. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008; 168 (6):649-56.
- 4. YADAV D., MUDDANA V., O’CONNELL M. Hospitalizations for chronic pancreatitis in Allegheny County, Pennsylvania, USA. Pancreatology. 2011; 11(6):546–52.
- 5. LOWENFELS A.B., MAISONNEUVE P., WHITCOMB D.C. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am. 2000; 84(3):565-73.
- 6. TAKEYAMA Y. Long-term prognosis of acute pancreatitis in Japan. Clin Gastroenterol Hepatol. 2009; 7(11 Suppl):S15-7.
- 7. LANKISCH P.G., LOWENFELS A.B., MAISONNEUVE P. What is the risk of alcoholic pancreatitis in heavy drinkers? Pancreas. 2002; 25(4):411-2.
- 8. GREER J.B., LARUSCH J., BRAND R.E., O’CONNELL M.R., YADAV D., WHITCOMB D.C. et al. ABO blood group and chronic pancreatitis risk in the NAPS2 cohort. Pancreas. 2011; 40(8):1188-94.
- 9. TRUNINGER K., SCHMID P.A., HOFFMANN M.M., BERTSCHINGER P., AMMANN R.W. Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndrome. Pancreas. 2006; 32(2):215–9.
- 10. ÖZHAN G., SARI F.M., VEFAI M., YANAR H.T., ALPERTUNGA B. Acute pancreatitis is associated with Ser608Leu iNOS polymorphism. Folia Biologica (Praha) 2012; 58(6):256-60.
- 11. GOTO Y., ANDO T., NAITO M., GOTO H., HAMAJIMA N. Inducible nitric oxide synthase polymorphism is associated with the increased risk of differentiated gastric cancer in a Japanese population. World J Gastroenterol. 2006; 12(39):6361-5.
- 12. XU W., CHARLES I.G., LIU L., MONCADA S., EMSON P. Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun. 1996; 219(3):784-8.
- 13. HANCOCK D.B., MARTIN E.R., VANCE J.M., SCOTT W.K. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics. 2008; 9(4):249-62.
- 14. SHEN J., WANG R.T., WANG L.W., XU Y.C., WANG X.R. A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J Gastroenterol. 2004; 10(22):3278-83.
- 15. HOBBS M.R., UDHAYAKUMAR V., LEVESQUE M.C., BOOTH J., ROBERTS J.M., TKACHUK A.N., et al. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet. 2002; 360(9344):1468-75.
- 16. FARKAS G. Jr., HOFNER P., BALOG A., TAKÁCS T., SZABOLCS A., FARKAS G. et al. Relevance of transforming growth factor-β1, interleukin-8, and tumor necrosis factor-a polymorphisms in patients with chronic pancreatitis. Eur. Cytokine Netw. 2007; 18(1):26-32.
- 17. OZHAN G., YANAR H.T., ERTEKIN C., ALPERTUNGA B. Polymorphisms in tumour necrosis factor alpha (TNFα) gene in patients with acute pancreatitis. Mediators Inflamm 2010; 2010:482950.
- 18. ZHANG L., WU G., HERRLE F., NIEDERGETHMANN M., KEESE M. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma. Cancer Genomics Proteomics 2012; 9(5):287-95.
- 19. LEVI F., LUCCHINI F., NEGRI E., LA VECCHIA C. Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas. 2003; 27(2):139-42.
- 20. CATALANO M.F., SAHAI A., LEVY M., ROMAGNUOLO J., WIERSEMA M., BRUGGE W. et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009; 69(7):1251-61.
- 21. CANZIAN F., FRANCESCHI S., PLUMMER M., VAN DOORN L.J., LU Y., GIOIA-PATRICOLA L. et al. Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev. 2008; 17(2):178-83.
- 22. HOLLA L.I., STEJSKALOVA A., ZNOJIL V., VASKU A. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases. Clin Exp Allergy. 2006; 36(12):1592-601.
- 23. JOHANNESEN J., PIE A., POCIOT F., KRISTIANSEN O.P., KARLSEN A.E., NERUP J. Linkage of the human inducible nitric oxide synthase gene to type I diabetes. J. Clin. Endocrinol. Metab. 2001; 86(6):2792-6.
- 24. MEARIN F., GARCIA-GONZALEZ M.A., STRUNK M., ZÁRATE N, MALAGELADA J.R., LANAS A. Association between achalasia and nitric oxide synthase gene polymorphisms. Am J Gastroenterol. 2006; 101(9):1979-84.
- 25. FERGUSON H.R., WILD C.P., ANDERSON L.A., MURPHY S.J., JOHNSTON B.T., MURRAY L.J., et al. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17(3):727-31.
- 26. LEE KM., KANG D., PARK S.K., BERNDT S.I., REDING D., CHATTERJEE N., et al. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis. 2009; 30(4):621-5.
- 27. JOHANNESEN J., POCIOT F., KRISTIANSEN O.P., KARLSEN A.E., NERUP J. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population. Genes Immun. 2000; 1(6):362-6.